SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 188,485.23 |
Enterprise Value ($M) | 241,013.67 |
Book Value ($M) | 65,259.00 |
Book Value / Share | 11.74 |
Price / Book | 2.92 |
NCAV ($M) | -65,748.00 |
NCAV / Share | -11.83 |
Price / NCAV | -2.87 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.16 |
Return on Assets (ROA) | 0.10 |
Return on Equity (ROE) | 0.26 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.13 |
Current Ratio | 1.40 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 47,739.00 |
Assets | 178,983.00 |
Liabilities | 113,487.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | n/a |
Net Income | 16,302.00 |
Earnings Per Share Diluted | 2.87 |
Earnings Per Share Basic | 2.92 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 12,588.00 |
Cash from Investing | -3,945.00 |
Cash from Financing | -3,945.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | State Street Corp | 5.03 | -4.37 | |
13G/A | Vanguard Group Inc | 8.06 | -0.44 | |
13G/A | BlackRock Inc. | 7.10 | -6.86 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
Quarterly Report – 10-Q | ||
Quarterly Report – 10-Q | ||
Quarterly Report – 10-Q | ||
Annual Report – 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,795,269 | 30,546,593 | 9.15 | |
3,985,944 | 37,614,200 | 10.60 | |
3,616,053 | 34,298,300 | 10.54 | |
3,752,908 | 28,126,400 | 13.34 | |
(click for more detail) |
|||
(click for list of largest short owners) |
Similar Companies | |
---|---|
NVO – Novo-Nordisk A/S | NVS – Novartis AG |
PBH – Prestige Brands Holdings, Inc. | PRGO – Perrigo Company plc |
QGEN – QIAGEN N.V. |
Financial data and stock pages provided by
Fintel.io